We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Sensor Measures Affect of Physical Activity on Diabetes

By LabMedica International staff writers
Posted on 11 Feb 2009
An under-the-skin glucose sensor measures the affect of physical activity on diabetes. More...
The sensor consists of a tiny electrode connected to a transmitter, which is attached to the skin with an adhesive patch.

The sensor can take nearly 300 readings per day and is to be used to monitor people with diabetes' glucose levels in a new study. Diabetes experts based at Southampton General Hospital (UK) will fit the tiny devices to participants' stomachs and use them in conjunction with watch-like armbands, which will check participants' physical activity. The study, the first of its kind in the United Kingdom, will determine how much of an impact exercise has on blood glucose levels while also taking diet and insulin intake into account.

Led by Prof. Christopher Byrne and Dr. Andrew Chipperfield, the study should shed new light on the management of type 1 diabetes. Thirty volunteers aged between 18 and 75 will be supplied with the sensor and armband. Weighing less than a 7 g, the waterproof electrode and transmitter will be replaced every three days. The physical activity armband will be worn for two blocks of 2 weeks during the 12-month study to record continuous data, which can then be downloaded electronically.

Dr. Victoria King, research manager at Diabetes UK said, "Physical activity is an essential part of managing type 1 diabetes and protecting against the serious complications of the condition such as heart disease, stroke, kidney failure, blindness, and amputation. We hope that this study will equip people with type 1 diabetes with the information they need to make pragmatic decisions about physical activity and how it is likely to affect their blood glucose control. This in turn will help to protect both their short- and long-term health.”

Related Links:

Southampton General Hospital



Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.